Caraco Pharmaceutical Laboratories Cephalexin Capsules, USP, 250 mg recall — FDA D-1510-2014
CGMP Deviations: These products are being recalled because they were manufactured with active pharmaceutical ingredients (APIs) that were not manufactured with good manufacturing practices.